Global CRISPR and Cas Genes Market to 2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,950	199 Pages	QualiKet Research	February, 2022	QUA17148961

Best Price Guarantee
Price	from $3,950
Length	199 Pages
Publisher	QualiKet Research
Published Date	February, 2022
SKU	QUA17148961

Global CRISPR and Cas Genes Market to 2027

Global CRISPR and Cas Genes Market to 2027

Market Overview

CRISPR and Cas is a unique technology which enables researchers to edit parts of the genome by either adding, removing, or altering sections of the DNA sequence. CRISPR and Cas is known as clustered regularly interspaced short palindromic repeats occurring in the genome of bacteria.

Market Drivers

Rise in government and private investments for development of novel therapies is the key driving factor which is expected to boost the global CRISPR and Cas genes market growth. Furthermore, rise in focus on development of novel therapeutics and increase in prevalence of various genetic disorders and cancer will have the positive impact on market growth. Moreover, Increase in technological advancements is expected to propel the global CRISPR and Cas genes market growth.

Market Restraints

However, high costs associated with use of CRISPR are major restraining factor which is expected to hamper the global CRISPR and Cas genes market growth. Also, ethical concerns regarding human genome editing will affect the market growth.

Market Segmentation

Global CRISPR and Cas Genes Market is segmented into product such as DNA-Free Cas, and Vector-Based Cas, by application such as Genome Engineering, Functional Genomics, Disease Models, and Knockdown/Activation. Further, market is segmented into end user such as Biotechnology & Pharmaceutical Companies, Contract Research Organizations, and Academic & Government Research Institutes.

Also, Global CRISPR and Cas Genes Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Market Key Players

Various key Players are discussed in this report such as GE Healthcare, Intellia Therapeutics, Horizon Discovery Group, Thermo Fisher Scientific, Takara Bio USA, Editas Medicine, Mirus Bio LLC, Merck KGaA, and CRISPR THERAPEUTICS

Market Taxonomy

By Product

DNA-Free Cas
Vector-Based Cas

By Application

Genome Engineering
Functional Genomics
Disease Models
Knockdown/Activation

By End User

Biotechnology & Pharmaceutical Companies
Contract Research Organizations
Academic & Government Research Institutes

By Region

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

1 Introduction: 1.1 Objective of the Study; 1.2 Market definition; 1.3 Market Scope
2 Research Methodology: 2.1 Data Mining; 2.2 Validation; 2.3 Primary Interviews; 2.4 List of Data Sources
3 Executive Summary
4 Global CRISPR and Cas Genes Market Outlook: 4.1 Overview; 4.2 Market Dynamics; 4.2.1 Drivers; 4.2.2 Restraints; 4.2.3 Opportunities; 4.3 Porters Five Force Model; 4.4 Value Chain Analysis
5 Global CRISPR and Cas Genes Market, By Product: 5.1 Y-o-Y Growth Comparison, By Product; 5.2 Global CRISPR and Cas Genes Market Share Analysis, By Product; 5.3 Global CRISPR and Cas Genes Market Size and Forecast, By Product; 5.3.1 DNA Free Cas; 5.3.2 Vector Based Cas
6 Global CRISPR and Cas Genes Market , By Application: 6.1 Y-o-Y Growth Comparison, By Application; 6.2 Global CRISPR and Cas Genes Market Share Analysis, By Application; 6.3 Global CRISPR and Cas Genes Market Size and Forecast, By Application; 6.3.1 Genome Engineering; 6.3.2 Functional Genomics; 6.3.3 Knockdown/Activation
7 Global CRISPR and Cas Genes Market, By End User: 7.1 Y-o-Y Growth Comparison, By End User; 7.2 Global CRISPR and Cas Genes Market Share Analysis, By End User; 7.3 Global CRISPR and Cas Genes Market Size and Forecast, By End User; 7.3. 1 Biotechnology & Pharmaceutical Companies; 7.3.2 Contract Research Organizations; 7.3.3 Academic & Government Research Institutes
8 Global CRISPR and Cas Genes Market, By Region: 8.1 Global CRISPR and Cas Genes Market Share Analysis, By Region; 8.2 Global CRISPR and Cas Genes Market Share Analysis, By Region; 8.3 Global CRISPR and Cas Genes Market Size and Forecast, By Region
9 North America CRISPR and Cas Genes Market Analysis and Forecast (2017 – 2027): 9.1 Introduction; 9.2 North America CRISPR and Cas Genes Market Share Analysis, By Product; 9.3 North America CRISPR and Cas Genes Market Size and Forecast, By Application; 9.4 North America CRISPR and Cas Genes Market Size and Forecast, By End User; 9.5 North America CRISPR and Cas Genes Market Size and Forecast, By Country; 9.5.1 U.S.; 9.5.2 Canada; 9.5.3 Mexico
10 Europe CRISPR and Cas Genes Market Analysis and Forecast (2017 – 2027): 10.1 Introduction; 10.2 Europe CRISPR and Cas Genes Market Share Analysis, By Product; 10.3 Europe CRISPR and Cas Genes Market Size and Forecast, By Application; 10.4 Europe CRISPR and Cas Genes Market Size and Forecast, By End User; 10.5 Europe CRISPR and Cas Genes Market Size and Forecast, By Country; 10.5.1 Germany; 10.5.2 France; 10.5.3 UK; 10.54. Rest of Europe
11 Asia Pacific CRISPR and Cas Genes Market Analysis and Forecast (2017 – 2027): 11.1 Introduction; 11.2 Asia Pacific CRISPR and Cas Genes Market Share Analysis, By Product; 11.3 Asia Pacific CRISPR and Cas Genes Market Size and Forecast, By Application; 11.4 Asia Pacific CRISPR and Cas Genes Market Size and Forecast, By End User; 11.5 Asia Pacific CRISPR and Cas Genes Market Size and Forecast, By Country; 11.5.1 China; 11.5.2 Japan; 11.5.3 India; 11.5.4. Rest of Asia Pacific
12 Latin America CRISPR and Cas Genes Market Analysis and Forecast (2017 – 2027): 12.1 Introduction; 12.2 Latin America CRISPR and Cas Genes Market Share Analysis, By Product; 12.3 Latin America CRISPR and Cas Genes Market Size and Forecast, By Application; 12.4 Latin America CRISPR and Cas Genes Market Size and Forecast, By End User; 12.5 Latin America CRISPR and Cas Genes Market Size and Forecast, Country
13 Middle East CRISPR and Cas Genes Market Analysis and Forecast (2017 – 2027): 13.1 Introduction; 13.2 Middle East CRISPR and Cas Genes Market Share Analysis, By Product; 13.3 Middle East CRISPR and Cas Genes Market Size and Forecast, By Application; 13.4 Middle East CRISPR and Cas Genes Market Size and Forecast, By End User; 13.5 Middle East CRISPR and Cas Genes Market Size and Forecast, By Country
14 Competitive Analysis: 14.1 Competition Dashboard; 14.2 Market share Analysis of Top Vendors; 14.3 Key Development Strategies
15 Company Profiles: 15.1 GE Healthcare; 15.1.1 Overview; 15.1.2 Offerings; 15.1.3 Key Financials; 15.1.4 Business Segment & Geographic Overview; 15.1.5 Key Market Developments; 15.1.6 Key Strategies; 15.2 Intellia Therapeutics; 15.2.1 Overview; 15.2.2 Offerings; 15.2.3 Key Financials; 15.2.4 Business Segment & Geographic Overview; 15.2.5 Key Market Developments; 15.2.6 Key Strategies; 15.3 Horizon Discovery Group; 15.3.1 Overview; 15.3.2 Offerings; 15.3.3 Key Financials; 15.3.4 Business Segment & Geographic Overview; 15.3.5 Key Market Developments; 15.3.6 Key Strategies; 15.4 Thermo Fisher Scientific; 15.4.1 Overview; 15.4.2 Offerings; 15.4.3 Key Financials; 15.4.4 Business Segment & Geographic Overview; 15.4.5 Key Market Developments; 15.4.6 Key Strategies; 15.5 Takara Bio USA; 15.5.1 Overview; 15.5.2 Offerings; 15.5.3 Key Financials; 15.5.4 Business Segment & Geographic Overview; 15.5.5 Key Market Developments; 15.5.6 Key Strategies; 15.6 Editas Medicine; 15.6.1 Overview; 15.6.2 Offerings; 15.6.3 Key Financials; 15.6.4 Business Segment & Geographic Overview; 15.6.5 Key Market Developments; 15.6.6 Key Strategies; 15.7 Mirus Bio LLC; 15.7.1 Overview; 15.7.2 Offerings; 15.7.3 Key Financials; 15.7.4 Business Segment & Geographic Overview; 15.7.5 Key Market Developments; 15.7.6 Key Strategies; 15.8 Merck KGaA; 15.8.1 Overview; 15.8.2 Offerings; 15.8.3 Key Financials; 15.8.4 Business Segment & Geographic Overview; 15.8.5 Key Market Developments; 15.8.6 Key Strategies; 15.9 CRISPR THERAPEUTICS; 15.9.1 Overview; 15.9.2 Offerings; 15.9.3 Key Financials; 15.9.4 Business Segment & Geographic Overview; 15.9.5 Key Market Developments; 15.9.6 Key Strategies